A study on the relationship of hypoxic region and therapeutic effect in pancreatic cancer
Not Applicable
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000041309
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients in extremely poor general condition. 2) Patients who have a history of previous abdominal radiotherapy that overlaps with the irradiation field of the current pancreatic cancer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relationship between hypoxic regions and 2-year overall survival
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link hypoxic tumor regions to therapeutic resistance in pancreatic ductal adenocarcinoma (PDAC)?
How does hypoxia-targeting therapy compare to standard-of-care chemotherapy in improving survival for locally advanced pancreatic cancer?
Which hypoxia-related biomarkers (e.g., CA9, VEGF) predict response to hypoxia-modifying interventions in Kyoto University's pancreatic cancer trial?
What adverse events are associated with hypoxia-targeting agents in combination with radiation therapy for pancreatic malignancies?
Are there synergistic effects of hypoxia-activated prodrugs and immune checkpoint inhibitors in treating hypoxic pancreatic tumors?